These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30191970)

  • 41. Function of low ADARB1 expression in lung adenocarcinoma.
    Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y
    PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
    Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J
    J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment.
    Li Y; Liu Y; Wang K; Xue D; Huang Y; Tan Z; Chen Y
    Mediators Inflamm; 2023; 2023():8646088. PubMed ID: 37181807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expression and role of SUZ12 in lung adenocarcinoma.
    Hu X; Hu C; Zhong P
    Cancer Med; 2024 Oct; 13(19):e70190. PubMed ID: 39400513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
    Li H; Tong L; Tao H; Liu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation and transcriptome analyses construct a prognostic model and reveal the suppressor role of VMO1 in lung adenocarcinoma.
    Wang L; Yin M; Zhang Z; Liu S; Liu Y; Geng X; Zheng G
    Cell Signal; 2024 Oct; 122():111313. PubMed ID: 39053673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma.
    Guo AY; Liang XJ; Liu RJ; Li XX; Bi W; Zhou LY; Tang CE; Yan A; Chen ZC; Zhang PF
    Cancer Biol Ther; 2017 Sep; 18(9):715-722. PubMed ID: 28825855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
    Hu B; Zhu X; Lu J
    Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. G protein gamma 7 suppresses progression of lung adenocarcinoma by inhibiting E2F transcription factor 1.
    Zheng H; Tian H; Yu X; Ren P; Yang Q
    Int J Biol Macromol; 2021 Jul; 182():858-865. PubMed ID: 33864871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis.
    Zhu J; Cheng H; Wang L; Xu W; Wang J; Han Q; Lee JH; Du L; Lyu J
    Mol Biol Rep; 2022 Aug; 49(8):7275-7286. PubMed ID: 35562515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZDHHC11B is decreased in lung adenocarcinoma and inhibits tumorigenesis via regulating epithelial-mesenchymal transition.
    Dai H; Wu R; Zhang J; Dou R; Xu M; Wang J; Wang J; Su F; Zhang T
    Cancer Med; 2023 Aug; 12(16):17212-17222. PubMed ID: 37434393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E
    Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L
    Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
    Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
    Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Yu J; Hou M; Pei T
    DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxia-inducible lipid droplet-associated (HILPDA) facilitates the malignant phenotype of lung adenocarcinoma cells in vitro through modulating cell cycle pathways.
    Sheng Y; Li J; Yang Y; Lu Y
    Tissue Cell; 2021 Jun; 70():101495. PubMed ID: 33535136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
    Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
    Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells.
    Dai Z; Xie B; Yang B; Chen X; Hu C; Chen Q
    Tissue Cell; 2023 Feb; 80():101974. PubMed ID: 36463587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.